Access to cancer expertise, support, and guidance
Combining Memorial Sloan Kettering’s clinical subspecialized expertise and superior patient outcomes, human-led cancer navigation, MSK Direct supports employees, no matter where they live.
The MSK Direct solution empowers employees to take control of their treatment plan with access to:
- Navigation to clinical care: Guidance to world-class care at MSK or locally
- Comprehensive support: Personalized navigation and support
- Expert medical opinions: Second opinions from world-renowned cancer experts
- Screening & prevention resources: Cancer screening tools and resources
Cancer in the workplace
A 2023 study published in BMJ Oncology revealed a 79.1% global increase (from 1990-2019) of early onset (ages 14-49) cancer diagnoses.1
50% of workers are afraid to disclose their cancer diagnosis for fear of stigma or losing their job.2
92% of cancer patients feel the support they receive from the workplace, positively affects their health.2
This puts employers in a powerful position to affect positive change.
Sources: 1BMJ Oncology, 2023; 2Working with Cancer Pledge, (n.d.).
Leading subspeciality expertise: MSK is 100% focused on cancer, subspecializing across 400+ common and rare cancers.
Superior outcomes: MSK has a 25% better 5-year survival rate compared to other hospitals.
An expert diagnosis and treatment plan: Getting the correct diagnosis first lowers unnecessary costs and improves outcomes.
Commitment to health equity
MSK Direct is an important element of MSK’s efforts to ensure there is equity in cancer care—so that each person has the resources, opportunities, and support they need to live a healthy life. It also means that people understand their cancer risk and have access to cancer screening, treatment, and survivorship care.
Our team at MSK has created a culture that embraces differences, expanding access to exceptional cancer care for all. We also offer resources and services in multiple languages.